Telomir Pharmaceuticals (TELO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.05, +0.00% vs the prior close of $1.05.
- Volume 34.63K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TELO ends flat (+0.0%) to $1.05, 6 down days in a row. Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.04–$1.13, opened at $1.04.
TELO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TELO ends flat (+0.0%) to $1.05, 6 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.04–$1.13, opened at $1.04.
- Volume was 34.63K shares, 0.4x its 50-day average of 90.73K — lighter than usual.
- Price is -8.8% vs its 50-day average ($1.15) and -15.5% vs its 200-day average ($1.24).
- 52-week range $0.89–$1.75; today's close sits at 19% of that range, 40.0% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — TELO ends flat (+0.0%) to $1.05, 5 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.01–$1.07, opened at $1.04.
- Volume was 69.30K shares, 0.8x its 50-day average of 90.84K.
- Price is -9.0% vs its 50-day average ($1.15) and -15.6% vs its 200-day average ($1.24).
- 52-week range $0.89–$1.75; today's close sits at 19% of that range, 40.0% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — TELO slides 3.7% to $1.05, a 1-month low, 4 down days in a row
- Closed at $1.05, -3.67% vs the prior close of $1.09. Day range $1.03–$1.11, opened at $1.10.
- Volume was 86.90K shares, 1.0x its 50-day average of 90.74K.
- Price is -9.2% vs its 50-day average ($1.16) and -15.7% vs its 200-day average ($1.25).
- 52-week range $0.89–$1.75; today's close sits at 19% of that range, 40.0% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — TELO dips 0.9% to $1.09, a 1-month low, 3 down days in a row
- Closed at $1.09, -0.91% vs the prior close of $1.10. Day range $1.08–$1.20, opened at $1.10.
- Volume was 53.80K shares, 0.6x its 50-day average of 90.76K — lighter than usual.
- Price is -5.9% vs its 50-day average ($1.16) and -12.6% vs its 200-day average ($1.25).
- 52-week range $0.89–$1.75; today's close sits at 23% of that range, 37.7% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — TELO dips 1.8% to $1.10, a 1-month low
- Closed at $1.10, -1.79% vs the prior close of $1.12. Day range $1.09–$1.14, opened at $1.13.
- Volume was 70.90K shares, 0.8x its 50-day average of 90.22K.
- Price is -5.3% vs its 50-day average ($1.16) and -11.9% vs its 200-day average ($1.25).
- 52-week range $0.89–$1.82; today's close sits at 23% of that range, 39.5% below the 52-week high.
Oct 9, 2026 — TELO dips 2.6% to $1.12
- Closed at $1.12, -2.61% vs the prior close of $1.15. Day range $1.10–$1.16, opened at $1.16.
- Volume was 64.60K shares, 0.7x its 50-day average of 90.31K.
- Price is -3.8% vs its 50-day average ($1.16) and -10.4% vs its 200-day average ($1.25).
- 52-week range $0.89–$2.09; today's close sits at 19% of that range, 46.4% below the 52-week high.
Oct 8, 2026 — TELO rises 2.7% to $1.15
- Closed at $1.15, +2.68% vs the prior close of $1.12. Day range $1.10–$1.15, opened at $1.11.
- Volume was 131.50K shares, 1.5x its 50-day average of 89.69K.
- Price is -1.4% vs its 50-day average ($1.17) and -8.1% vs its 200-day average ($1.25).
- 52-week range $0.89–$2.09; today's close sits at 22% of that range, 45.0% below the 52-week high.
Oct 7, 2026 — TELO slides 6.7% to $1.12
- Closed at $1.12, -6.67% vs the prior close of $1.20. Day range $1.12–$1.17, opened at $1.16.
- Volume was 124.50K shares, 1.4x its 50-day average of 89.60K.
- Price is -4.1% vs its 50-day average ($1.17) and -10.6% vs its 200-day average ($1.25).
- 52-week range $0.89–$2.09; today's close sits at 19% of that range, 46.4% below the 52-week high.
Oct 6, 2026 — TELO dips 0.8% to $1.20 on 19.0x normal volume
- Closed at $1.20, -0.83% vs the prior close of $1.21. Day range $1.17–$1.58, opened at $1.25.
- Volume was 1.25M shares, 19.0x its 50-day average of 65.84K — unusually heavy trading.
- Price is +2.7% vs its 50-day average ($1.17) and -4.3% vs its 200-day average ($1.25).
- 52-week range $0.89–$2.09; today's close sits at 26% of that range, 42.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — TELO rises 2.5% to $1.21 on 2.1x normal volume
- Closed at $1.21, +2.54% vs the prior close of $1.18. Day range $1.19–$1.27, opened at $1.24.
- Volume was 134.40K shares, 2.1x its 50-day average of 64.79K — unusually heavy trading.
- Price is +3.5% vs its 50-day average ($1.17) and -3.6% vs its 200-day average ($1.26).
- 52-week range $0.89–$2.09; today's close sits at 27% of that range, 42.1% below the 52-week high.
Oct 2, 2026 — TELO rises 0.9% to $1.18
- Closed at $1.18, +0.85% vs the prior close of $1.17. Day range $1.17–$1.22, opened at $1.17.
- Volume was 74.10K shares, 1.1x its 50-day average of 65.89K.
- Price is +1.0% vs its 50-day average ($1.17) and -6.1% vs its 200-day average ($1.26).
- 52-week range $0.89–$2.09; today's close sits at 24% of that range, 43.6% below the 52-week high.
TELO latest news & SEC filings
Every SEC filing by or about TELO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.72M (prior year -$5.07M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.79 (prior year -$0.17) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TELO
- How much it moves: over the last 20 sessions the average daily move was 1.95% (largest 6.7%).
- Liquidity: about 128.95K shares (≈$135.40K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.05 vs a range of $0.89–$1.75 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 17, 2026; 8-K Sep 16, 2026.
- Share count: 68.77M shares outstanding (Aug 12, 2026), +113.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TELO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.04 | 1.13 | 1.04 | 1.05 | 34.63K |
| Oct 15, 2026 | 1.04 | 1.07 | 1.01 | 1.05 | 69.30K |
| Oct 14, 2026 | 1.10 | 1.11 | 1.03 | 1.05 | 86.90K |
| Oct 13, 2026 | 1.10 | 1.20 | 1.08 | 1.09 | 53.80K |
| Oct 12, 2026 | 1.13 | 1.14 | 1.09 | 1.10 | 70.90K |
| Oct 9, 2026 | 1.16 | 1.16 | 1.10 | 1.12 | 64.60K |
| Oct 8, 2026 | 1.11 | 1.15 | 1.10 | 1.15 | 131.50K |
| Oct 7, 2026 | 1.16 | 1.17 | 1.12 | 1.12 | 124.50K |
| Oct 6, 2026 | 1.25 | 1.58 | 1.17 | 1.20 | 1.25M |
| Oct 5, 2026 | 1.24 | 1.27 | 1.19 | 1.21 | 134.40K |
| Oct 2, 2026 | 1.17 | 1.22 | 1.17 | 1.18 | 74.10K |
| Oct 1, 2026 | 1.20 | 1.22 | 1.15 | 1.17 | 59.70K |
| Sep 30, 2026 | 1.19 | 1.24 | 1.17 | 1.20 | 43.30K |
| Sep 29, 2026 | 1.19 | 1.20 | 1.16 | 1.17 | 34.30K |
| Sep 28, 2026 | 1.24 | 1.24 | 1.17 | 1.20 | 72.10K |
| Sep 25, 2026 | 1.22 | 1.23 | 1.20 | 1.23 | 56.00K |
| Sep 24, 2026 | 1.21 | 1.24 | 1.21 | 1.21 | 31.10K |
| Sep 23, 2026 | 1.24 | 1.25 | 1.21 | 1.22 | 34.60K |
| Sep 22, 2026 | 1.25 | 1.29 | 1.21 | 1.25 | 103.20K |
| Sep 21, 2026 | 1.23 | 1.25 | 1.19 | 1.24 | 46.40K |
About Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI, FL. State of incorporation: FL. Fiscal year ends December 31. SEC CIK 1971532.
TELO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Erez Aminov | CEO and Chairman | May 22, 2026 |
| Giudice Matthew Paul Del | Director | Jul 27, 2026 |
| Edward Clouston Macpherson | Director | Jul 27, 2026 |
| Matthew Pratt Whalen | Director | Jul 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Erez Aminov | CEO and Chairman | May 22, 2026 |
| Andriy Mushak | Chief Financial Officer | Jun 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
TELO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.41M | -0.33 | $-3.69M |
| Dec 31, 2024 | — | $-16.53M | -0.56 | $-5.07M |
| Dec 31, 2023 | — | $-13.07M | 0.48 | $-3.86M |
| Dec 31, 2022 | — | $-854.15K | -0.03 | $-468.66K |
Latest balance sheet: total assets $5.37M, total liabilities $332.42K, cash $754.32K (as of Jun 30, 2026).
TELO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TELO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.